Almitrine is a respiratory stimulant that enhances respiration by acting as an agonist of peripheral chemoreceptors located on the carotid bodies. It is used in the treatment of chronic obstructive... It is also reported to have a potentially beneficial effect in treating the noctural oxygen desaturation without impairing the quality of sleep.
- Mechanism
- Curator reviewed
Almitrine is an agonist at the peripheral chemoreceptors expressed on carotid bodies. It enhances respiration in patients with chronic obstructive pulmonary disease by increasing the arterial oxygen tension while decreasing the arterial carbon dioxide tension.
- Primary indication
- For the treatment of chronic obstructive pulmonary disease.Curator reviewed · 13 structured indications
- Formula / weight
- C26H29F2N7 · 477.5522 g/mol (avg)
- Code names
- SE 5023
Resolves to
OBDOVFRMEYHSQB-UHFFFAOYSA-NSMILESFC1=CC=C(C=C1)C(N1CCN(CC1)C1=NC(NCC=C)=NC(NCC=C)=N1)C1=CC=C(F)C=C1What you can answer from here — as of September 23, 2026
Which drugs share a target with Almitrine, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account